{"title":"甲氨蝶呤治疗耐药ENL。","authors":"Bikash R Kar, Ravindra Babu","doi":"10.1489/1544-581X(2004)72<480:MIRE>2.0.CO;2","DOIUrl":null,"url":null,"abstract":"<p><p>This is a report of a case of steroid resistant severe Type 2 reaction that was managed with methotrexate and prednisolone. Synergistic action of both the drugs in severe Type 2 reaction make them one of the preferred combinations in the absence of other agents such as thalidomide.</p>","PeriodicalId":14078,"journal":{"name":"International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association","volume":"72 4","pages":"480-2"},"PeriodicalIF":0.0000,"publicationDate":"2004-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"22","resultStr":"{\"title\":\"Methotrexate in resistant ENL.\",\"authors\":\"Bikash R Kar, Ravindra Babu\",\"doi\":\"10.1489/1544-581X(2004)72<480:MIRE>2.0.CO;2\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>This is a report of a case of steroid resistant severe Type 2 reaction that was managed with methotrexate and prednisolone. Synergistic action of both the drugs in severe Type 2 reaction make them one of the preferred combinations in the absence of other agents such as thalidomide.</p>\",\"PeriodicalId\":14078,\"journal\":{\"name\":\"International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association\",\"volume\":\"72 4\",\"pages\":\"480-2\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2004-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"22\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1489/1544-581X(2004)72<480:MIRE>2.0.CO;2\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1489/1544-581X(2004)72<480:MIRE>2.0.CO;2","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
This is a report of a case of steroid resistant severe Type 2 reaction that was managed with methotrexate and prednisolone. Synergistic action of both the drugs in severe Type 2 reaction make them one of the preferred combinations in the absence of other agents such as thalidomide.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
